Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-09-19
2006-09-19
Ulm, John (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S139100
Reexamination Certificate
active
07109307
ABSTRACT:
Novel TNF receptor death domain (“TNF-R1-DD”) ligand proteins are disclosed. Polynucleotides encoding the TNF-R1-DD ligand protein are also disclosed, along with vectors, host cells, and methods of making the TNF-R1-DD ligand protein. Pharmaceutical compositions containing the TNF-R1-DD ligand protein, methods of treating inflammatory conditions, and methods of inhibiting TNF-R death domain binding are also disclosed. Methods of identifying inhibitors of TNF-R death domain binding and inhibitors identified by such methods are also disclosed.
REFERENCES:
patent: 4703004 (1987-10-01), Hopp et al.
patent: 5296592 (1994-03-01), Dower et al.
patent: 5464938 (1995-11-01), Smith et al.
patent: 5506340 (1996-04-01), Heavner
patent: 5563039 (1996-10-01), Goeddel et al.
patent: 0 308 378 (1989-03-01), None
patent: 0 393 438 (1990-10-01), None
patent: 0 433 900 (1991-06-01), None
patent: 0 526 905 (1993-02-01), None
patent: 0 585 939 (1994-03-01), None
patent: WO 92/03470 (1992-03-01), None
patent: WO 92/03471 (1992-03-01), None
patent: WO 92/14834 (1992-09-01), None
patent: WO 93/19777 (1993-10-01), None
patent: WO 94/01548 (1994-01-01), None
patent: WO 94/10207 (1994-05-01), None
patent: WO 95/31544 (1995-11-01), None
patent: WO 95/33051 (1995-12-01), None
patent: WO 96/34095 (1996-10-01), None
Miki, et al. (1992). “Disruption of the APC Gene by a Retrotransposal Insertion of L1 Sequence in a Colon Cancer”Cancer Res. 52:643-645.
Damay, et al. (1994). “Identification of a Protein Kinase Associated with the Cytoplasmic Domain of the p60 Tumor Necrosis Factor Receptor”J. Biol. Chem. 269(32):20299-20304.
Kiefer, et al. (1992). “Characterization of Recombinant Human Insulin-like Growth Factor Binding Proteins 4,5 and 6 Produced in Yeast”J. Biol. Chem. 267(18):12692-12699.
Genbank Accession No. T08593 (May 23, 1993).
GenBank Accession No. T07800 (Jul. 21, 2000).
GenBank Accession No. M78050 (May 26, 1992).
GenBank Accession No. M78539 (May 26, 1992).
GenBank Accession No. U44953 (Jul. 1, 1996).
GenBank Accession No. U48254 (Aug. 3, 1996).
Tartaglia, et al. (1992). “Tumor Necrosis Factor Receptor Signaling”J. Biol. Chem. 267(7):4304-4307.
Tartaglia, et al. (1993). “Tumor Necrosis Factor's Cytotoxic Activity is Signaled by the p55 TNF Receptor”Cell73:213-216.
Gyuris, et al. (1993). “Cdi1, a Human G1 and S Phase Protein Phosphatase That Associates with Cdk2”Cell75:791-803.
Schall, et al. (1990). “Molecular Cloning and Expression of a Receptor for Human Tumor Necrosis Factor”Cell61:361-370.
Shimasaki, et al. (1991). “Identification of Five Different Insulin-like Growth Factor Binding Proteins from Adult Rat Serum and Molecular Cloning of a Novel IGFBP-5 in Rat and Human”J. Biol. Chem. 266(16):10646-10653.
Saragovi, et al. (1992). “Loops and Secondary Structure Mimetics: Development and Applications in Basic Science and Rational Drug Design”BioTechnology10:773-778.
McDowell, et al. (1992). “Structural Studies of Potent Constrained RGD Peptides”J. Am. Chem. Soc. 114(24):9245-9253.
Kaufman, et al. (1991). “Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus”Nucleic Acids Res. 19(16):4485-4490.
Kaufman, et al. (1990). “Selection and Coamplification of Heterologous Genes in Mammalian Cells”Methods in Enzymology185:537-566.
Gietz, et al. (1992) “Improved method for high efficiency transformation of intact yeast cells”Nucleic Acids Res. 20(6):1425.
Waye, et al. (1995). “Gene expression of adult human heart as revealed by random sequencing of cDNA library”Protein Engineering8:90.
Auffray, et al. (1995). “IMAGE: integrated molocular analysis of the human genome and its expression”Life Sciences318:263-272. English Abstract.
Rothe, et al. (1994). “A Novel Family of Putative Signal Transducers Associated with the Cytopolasmic Domain of the 75 kDa Tumor Necrosis Factor Receptor”Cell78:681-692.
Song, et al. (1994). “Aggregation of the Intracellular Domain of the Type 1 Tumor Necrosis Factor Receptor Defined by the Two-hybrid System”J. Biol. Chem. 269(36):22492-22495.
Tartaglia, et al. (1993). “A Novel Domain within the 55 kd TNF Receptor Signals Cell Death”Cell74:845-853.
Boldin, et al. (1995). “Self-association of the “Death Domains” of the p55 Tumor Necrosis Factor Receptor and Fas/APO1 Prompts Signaling for the TNF and Fas/ PO1 Effects”J. Biol. Chem. 270:387-391.
Hsu, et al., (1995). “The TNF Receptor 1-Associated Protein TRADD Signals Cell Death and NF-κB Activation”Cell81:495-504.
Boldin, et al. (1995). “A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its ‘death domain’”FEBS Letters267:39-44.
Adams, et al. (1992). “Sequence identification of 2,375 human brain genes”Nature355:632-634.
Adams, et al. (1993). “Rapid cDNA sequencing from a directionally cloned human infant brain cDNA library”Nature Genetics4:373-380.
Chen Jennifer
Graham James
Lin Lih-Ling
Schievella Andrea R.
Elriffi, Esq. Ivor R.
Mintz Levin Cohn Ferris Glovsky, P.C.
Ulm John
LandOfFree
TNF receptor death domain ligand proteins and inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with TNF receptor death domain ligand proteins and inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TNF receptor death domain ligand proteins and inhibitors of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3550573